<main lang="en" class="publication" role="main">
      


<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    

<div class="gem-c-title govuk-!-margin-top-8 govuk-!-margin-bottom-8">
      <span class="govuk-caption-xl gem-c-title__context">
    Decision
  </span>

  
  <h1 class="gem-c-title__text govuk-heading-l">
    Regulatory approval of Pfizer/BioNTech vaccine for COVID-19
  </h1>
</div>
  </div>
  

  <div class="govuk-grid-column-two-thirds">
    
  <p class="gem-c-lead-paragraph">Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.</p>

  </div>
</div>

<div class="govuk-grid-row">
  <div class="metadata-logo-wrapper">
    <div class="govuk-grid-column-two-thirds metadata-column">
      <div class="gem-c-metadata" data-module="gem-toggle">
  <dl data-module="gem-track-click">
      <dt class="gem-c-metadata__term">From:</dt>
      <dd class="gem-c-metadata__definition">
          <a class="govuk-link" href="/government/organisations/medicines-and-healthcare-products-regulatory-agency">Medicines and Healthcare products Regulatory Agency</a>

      </dd>
      <dt class="gem-c-metadata__term">Published</dt>
      <dd class="gem-c-metadata__definition">2 December 2020</dd>
      <dt class="gem-c-metadata__term">Last updated</dt>
      <dd class="gem-c-metadata__definition">
        24 December 2021
          â€” <a data-track-action="see-all-updates-link-clicked" data-track-category="content-history" data-track-label="history" href="#history" class="gem-c-metadata__definition-link govuk-!-display-none-print">
            See all updates
          </a>
      </dd>
  </dl>
</div>
    </div>
    <div class="govuk-grid-column-one-third">
    </div>
  </div>
</div>








<div class="govuk-grid-row">
  <div class="govuk-grid-column-two-thirds">
    <div class="responsive-bottom-margin">
      
  <section class="gem-c-devolved-nations">
    <h2 class="govuk-heading-s govuk-!-margin-bottom-0">
      Applies to England, Scotland and Wales
</h2>
</section>
      <div class="responsive-bottom-margin">
          <section>
    <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Documents</h2>


      
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak direction-ltr">
    
        <section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine" class="thumbnail" tabindex="-1"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-healthcare-professionals-on-pfizerbiontech-covid-19-vaccine" class="govuk-link">Information for Healthcare Professionals on COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043778/Temporary_Authorisation_HCP_Information_BNT162_19_0_UK_Clean.pdf"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043778/thumbnail_Temporary_Authorisation_HCP_Information_BNT162_19_0_UK_Clean.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043778/Temporary_Authorisation_HCP_Information_BNT162_19_0_UK_Clean.pdf">Information for Healthcare Professionals on COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">540 KB</span>, <span class="page-length" lang="en">18 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine">Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043779/Temporary_Authorisation_Patient_Information_BNT162_18_0_UK_Clean.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043779/thumbnail_Temporary_Authorisation_Patient_Information_BNT162_18_0_UK_Clean.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043779/Temporary_Authorisation_Patient_Information_BNT162_18_0_UK_Clean.pdf">Information for UK recipients on COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">130 KB</span>, <span class="page-length" lang="en">5 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine" class="thumbnail"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/conditions-of-authorisation-for-pfizerbiontech-covid-19-vaccine">Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022642/Conditions_of_authorisation_for_Pfizer_BioNTech_vaccine__27_Sept.pdf" tabindex="-1" class="thumbnail"><img src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022642/thumbnail_Conditions_of_authorisation_for_Pfizer_BioNTech_vaccine__27_Sept.pdf.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1022642/Conditions_of_authorisation_for_Pfizer_BioNTech_vaccine__27_Sept.pdf" class="govuk-link">Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech (Regulation 174)</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">163 KB</span>, <span lang="en" class="page-length">7 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-of-product-characteristics-for-covid-19-vaccine-pfizerbiontech" class="thumbnail" tabindex="-1"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-of-product-characteristics-for-covid-19-vaccine-pfizerbiontech" class="govuk-link">Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038278/Comirnaty_clean_SmPC__002_.pdf"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038278/thumbnail_Comirnaty_clean_SmPC__002_.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a aria-describedby="attachment-6269821-accessibility-help" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1038278/Comirnaty_clean_SmPC__002_.pdf" class="govuk-link">Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">581 KB</span>, <span lang="en" class="page-length">22 pages</span>
    </p>


      <div data-module="toggle" class="accessibility-warning">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary data-track-action="FormatRequestClicked" data-details-track-click="" data-track-label="Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech" class="govuk-details__summary" data-module="govuk-details" data-track-category="Accessible Format Request">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Summary%20of%20Product%20Characteristics%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Summary%20of%20Product%20Characteristics%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/patient-information-leaflet-for-covid-19-vaccine-pfizerbiontech"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/patient-information-leaflet-for-covid-19-vaccine-pfizerbiontech">Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033607/Comirnaty_PIL_clean.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033607/thumbnail_Comirnaty_PIL_clean.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1033607/Comirnaty_PIL_clean.pdf" aria-describedby="attachment-6269823-accessibility-help">Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">475 KB</span>, <span class="page-length" lang="en">9 pages</span>
    </p>


      <div data-module="toggle" class="accessibility-warning">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-track-label="Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech" data-track-action="FormatRequestClicked" data-details-track-click="" data-module="govuk-details" data-track-category="Accessible Format Request">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Patient%20Information%20Leaflet%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Patient%20Information%20Leaflet%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-public-assessment-report-for-pfizerbiontech-covid-19-vaccine"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-public-assessment-report-for-pfizerbiontech-covid-19-vaccine">Summary of the Public Assessment Report for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" class="thumbnail" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/patient-information-leaflet-for-covid-19-vaccine-pfizerbiontech-10-micrograms"><img alt="" src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/patient-information-leaflet-for-covid-19-vaccine-pfizerbiontech-10-micrograms">Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech 10 micrograms </a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a tabindex="-1" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043379/Patient_Information_Leaflet_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf" class="thumbnail"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043379/thumbnail_Patient_Information_Leaflet_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043379/Patient_Information_Leaflet_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf" class="govuk-link">Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech 10 micrograms </a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">527 KB</span>, <span class="page-length" lang="en">9 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043378/Summary_of_Product_Characteristics_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043378/thumbnail_Summary_of_Product_Characteristics_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043378/Summary_of_Product_Characteristics_for_COVID-19_Vaccine_Pfizer_BioNTech_10_micrograms.pdf" class="govuk-link"> Summary of product characteristics for COVID-19 Vaccine Pfizer/BioNTech 10 micrograms</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">726 KB</span>, <span class="page-length" lang="en">21 pages</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-of-product-characteristics-for-covid-19-vaccine-pfizerbiontech-10-micrograms" tabindex="-1"><img src="https://www.gov.uk/assets/whitehall/pub-cover-html-b0465911e56983d98c70f0e25fba24bc206d37e8c83d4addf6421dcf6022c6cd.png" alt=""></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a href="/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/summary-of-product-characteristics-for-covid-19-vaccine-pfizerbiontech-10-micrograms" class="govuk-link">Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech 10 micrograms</a></h3>
    <p class="govuk-body metadata">
        <span class="type">HTML</span>
    </p>


  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043405/Comirnaty_GB_CMA_Conditions.pdf" tabindex="-1"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043405/thumbnail_Comirnaty_GB_CMA_Conditions.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1043405/Comirnaty_GB_CMA_Conditions.pdf" aria-describedby="attachment-6269829-accessibility-help">Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">92.9 KB</span>, <span lang="en" class="page-length">2 pages</span>
    </p>


      <div data-module="toggle" class="accessibility-warning">
        <p class="govuk-body">This file may not be suitable for users of assistive technology.</p>
        <details class="gem-c-details govuk-details govuk-!-margin-bottom-3" data-module="govuk-details gem-details">
  <summary class="govuk-details__summary" data-module="govuk-details" data-track-action="FormatRequestClicked" data-track-category="Accessible Format Request" data-details-track-click="" data-track-label="Conditions of Authorisation for COVID-19 Vaccine Pfizer/BioNTech">
    <span class="govuk-details__summary-text">
      Request an accessible format.
    </span>
</summary>  <div class="govuk-details__text">
    
          If you use assistive technology (such as a screen reader) and need a
version of this document in a more accessible format, please email <a href="mailto:webupdates@mhra.gov.uk?body=Details%20of%20document%20required%3A%0A%0A%20%20Title%3A%20Conditions%20of%20Authorisation%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%0A%20%20Original%20format%3A%20pdf%0A%0APlease%20tell%20us%3A%0A%0A%20%201.%20What%20makes%20this%20format%20unsuitable%20for%20you%3F%0A%20%202.%20What%20format%20you%20would%20prefer%3F%0A%20%20%20%20%20%20&amp;subject=Request%20for%20%27Conditions%20of%20Authorisation%20for%20COVID-19%20Vaccine%20Pfizer%2FBioNTech%27%20in%20an%20alternative%20format">webupdates@mhra.gov.uk</a>.
Please tell us what format you need. It will help us if you say what assistive technology you use.


  </div>
</details>      </div>
  </div>
</section><section class="attachment embedded">
  <div class="attachment-thumb">
      <a class="thumbnail" tabindex="-1" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/997584/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH_ext_of_indication_11.6.2021.pdf"><img alt="" src="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/997584/thumbnail_COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH_ext_of_indication_11.6.2021.pdf.png"></a>
  </div>
  <div class="attachment-details">
    <h3 class="title govuk-!-font-size-27 govuk-!-font-weight-regular"><a class="govuk-link" href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/997584/COVID-19_mRNA_Vaccine_BNT162b2__UKPAR___PFIZER_BIONTECH_ext_of_indication_11.6.2021.pdf">Public Assessment Report for COVID-19 Vaccine Pfizer/BioNTech</a></h3>
    <p class="govuk-body metadata">
        <span class="type"><abbr title="Portable Document Format">PDF</abbr></span>, <span class="file-size">4.1 MB</span>, <span class="page-length" lang="en">74 pages</span>
    </p>


  </div>
</section>

</div>
  </section>


        <section>
          <h2 class="gem-c-heading gem-c-heading--font-size-27 gem-c-heading--mobile-top-margin">Details</h2>


          
<div data-module="govspeak" class="gem-c-govspeak govuk-govspeak direction-ltr">
    
            <div class="govspeak">
<div class="call-to-action">
<p>The 15-minute observation period following a vaccination with COVID-19 vaccine Pfizer/BioNTech or Moderna will be temporarily suspended as part of measures to increase the booster rollout. Regulatory documents remain unchanged.</p>
</div>

<p>To date, the COVID-19 Vaccine Pfizer/BioNTech has been supplied in the UK on a temporary basis under Regulation 174 of the Human Medicine Regulations 2012, but as this was always intended to be a temporary arrangement, supply of this vaccine will change to be in accordance with the conditional Marketing Authorisation (CMA).</p>

<p>The product information for the CMA that was granted for Great Britain can be found on this page. This CMA was issued by the European Medicines Agency (EMA) on 21 December 2020 and was automatically converted to a GB CMA on 1 January 2021. <a class="govuk-link" href="https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty" rel="external">The CMA issued by the EMA</a> has continued to have effect in Northern Ireland since 21 December 2020.</p>

<p>Manufacture of the vaccine remains unchanged, as do the clinical, pharmacological and pharmaceutical properties of the vaccine.</p>

<p>The information for healthcare professionals and UK recipients on using the vaccine safely has been periodically updated as new data have become available and this will continue under the CMA. Please regularly check this information as it is often updated.</p>

<p>The product information for the COVID-19 Vaccine Pfizer/BioNTech authorised under Regulation 174 can also be found on this page while the R174 product remains in use.</p>

<p>The MHRA regularly publishesâ€¯<a class="govuk-link" href="https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting">reports of the safety of the COVID-19 vaccines</a>.</p>

<p>For further information on prioritising the first COVID-19 vaccine dose see theâ€¯<a href="https://www.gov.uk/government/publications/prioritising-the-first-covid-19-vaccine-dose-jcvi-statement" class="govuk-link">statement from the Joint Committee on Vaccination and Immunisation (JCVI)</a>.</p>

</div>

</div>
        </section>
      </div>

      <div data-module="gem-toggle" lang="en" class="app-c-published-dates app-c-published-dates--history govuk-!-margin-bottom-3">
    Published 2 December 2020
    <br>Last updated 24 December 2021
      <a href="#full-history" data-controls="full-history" data-toggled-text="-&nbsp;hide all updates" data-expanded="false" class="app-c-published-dates__toggle govuk-link">+&nbsp;show all updates</a>
      <div class="app-c-published-dates__change-history js-hidden">
        <ol class="app-c-published-dates__list">
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-24T01:06:11.000+00:00">24 December 2021</time>
              <p class="app-c-published-dates__change-note">Information for Healthcare Professionals and UK recipients on COVID-19 Vaccine Pfizer/BioNTech (Regulation 174) was updated</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-12-22T23:24:11.000+00:00" class="app-c-published-dates__change-date timestamp">22 December 2021</time>
              <p class="app-c-published-dates__change-note">Added HTML document for Summary of product characteristics for Comirnaty 10 micrograms/dose concentrate for dispersion for injection</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-22T14:43:13.000+00:00">22 December 2021</time>
              <p class="app-c-published-dates__change-note">Added Patient Information Leaflet and Summary of Product Characteristics for COVID-19 Vaccine Pfizer/BioNTech 10 micrograms</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-14T16:28:40.000+00:00">14 December 2021</time>
              <p class="app-c-published-dates__change-note">Banner added to main page: The 15 minute observation period following a vaccination with Pfizer/BioNTech or Moderna will be temporarily suspended as part of measures to increase the booster rollout. Regulatory documents remain unchanged.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-12-03T11:33:50.000+00:00">3 December 2021</time>
              <p class="app-c-published-dates__change-note">The Pfizer/BioNTech vaccine (Comirnaty) Conditional Marketing Authorisation has been renewed: changes to the SmPC â€“ section 9 and section 10.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-11-15T22:45:46.000+00:00" class="app-c-published-dates__change-date timestamp">15 November 2021</time>
              <p class="app-c-published-dates__change-note">Updated sections of the Summary of Product Characteristics and Patient Information Leaflet for COVID-19 Vaccine Pfizer/BioNTech (Conditional Marketing Authorisation documents) to include information about receiving a 3rd/booster dose. Also to include two new reagents, Sodium Hydroxide and Hydrochloric Acid, which are used in small quantities during the preparation of one of the solutions used in the manufacturing process. The official International non-proprietary name â€˜tozinameranâ€™ has also been added.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-10-28T14:41:41.000+01:00" class="app-c-published-dates__change-date timestamp">28 October 2021</time>
              <p class="app-c-published-dates__change-note">Updated figures in HCP information Table 5: Vaccine efficacy â€“ First COVID-19 occurrence from 7 days after Dose 2 â€“ participants without evidence of infection and with or without evidence of infection prior to 7 days after Dose 2 â€“ adolescents 12 to 15 years of age evaluable efficacy (7 days) population</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-10-27T17:50:56.000+01:00" class="app-c-published-dates__change-date timestamp">27 October 2021</time>
              <p class="app-c-published-dates__change-note">Update to the summary of product characteristics and patient information leaflet for the Pfizer/BioNTech vaccine condition marketing authorisation documents</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-10-27T11:56:02.000+01:00" class="app-c-published-dates__change-date timestamp">27 October 2021</time>
              <p class="app-c-published-dates__change-note">Updated for both HCPs and public</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-09-27T17:02:35.000+01:00">27 September 2021</time>
              <p class="app-c-published-dates__change-note">Extended vaccine shelf life from 6 months to now 9 months.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-09-09T07:01:39.000+01:00" class="app-c-published-dates__change-date timestamp">9 September 2021</time>
              <p class="app-c-published-dates__change-note">Updated sections of Information for Healthcare Professionals on COVID-19 Pfizer/BioNTech (Regulation 174) and Information for UK recipients on COVID-19 Vaccine Pfizer/BioNTech (Regulation 174) to include information about receiving a third dose. Also updated the Regulation 174 Conditions document with an additional pharmacovigilance condition.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-08-11T18:33:12.000+01:00" class="app-c-published-dates__change-date timestamp">11 August 2021</time>
              <p class="app-c-published-dates__change-note">Updates to the Conditional Marketing Authorisation SmPC and PIL and updates to the Regulation 174 Information for Healthcare Professionals and Information for recipients</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-08-02T09:19:15.000+01:00" class="app-c-published-dates__change-date timestamp">2 August 2021</time>
              <p class="app-c-published-dates__change-note">Updated conditions of authorisation for Pfizer BioNTech vaccine</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-07-09T10:34:47.000+01:00" class="app-c-published-dates__change-date timestamp">9 July 2021</time>
              <p class="app-c-published-dates__change-note">We have published the Summary of Product Information, Patient Information Leaflet and Conditions document for the GB Conditional Marketing Authorisation of the Pfizer/BioNTech vaccine.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-06-28T14:53:38.000+01:00">28 June 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Public Assessment report, to reflect the extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its use in 12- to 15-year-olds, as announced on 4 June 2021.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-06-25T20:33:31.000+01:00" class="app-c-published-dates__change-date timestamp">25 June 2021</time>
              <p class="app-c-published-dates__change-note">Added a warning on myocarditis to the Information for UK recipients and the Information for Healthcare Professionals</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-06-04T11:03:31.000+01:00">4 June 2021</time>
              <p class="app-c-published-dates__change-note">Updated Conditions of Authorisation, Information for Healthcare Professionals and Information for UK Recipients documents in line with an extension to the current UK approval of the Pfizer/BioNTech COVID-19 vaccine that allows its use in 12- to 15-year-olds.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-05-20T16:29:26.000+01:00">20 May 2021</time>
              <p class="app-c-published-dates__change-note">Updated the Information for Healthcare Professionals, Information for UK recipients and Conditions of Authorisation documents. This is to reflect a change that once removed from the freezer, the undiluted vaccine has a maximum shelf life of up to 1 month (31 days). This was previously 5 days.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-03-31T17:14:52.000+01:00">31 March 2021</time>
              <p class="app-c-published-dates__change-note">Published new versions of the Conditions of Authorisation documents, with an additional clause in the Deployment section relating to transfers of frozen vials stored at ultra-low temperature and handling of temperature excursions</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-03-09T16:11:44.000+00:00" class="app-c-published-dates__change-date timestamp">9 March 2021</time>
              <p class="app-c-published-dates__change-note">Added information on fevers to Section 4 of Information for UK Recipients and section 4.8 of Information for Healthcare Professionals.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2021-01-28T11:45:07.000+00:00">28 January 2021</time>
              <p class="app-c-published-dates__change-note">Published new versions of the Conditions of Authorisation documents, with an additional clause relating to off-label prescribing</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2021-01-26T17:18:36.000+00:00" class="app-c-published-dates__change-date timestamp">26 January 2021</time>
              <p class="app-c-published-dates__change-note">We have updated the Product Information to state that the vaccine is manufactured with enough volume for six doses, if our latest guidance for Healthcare Professionals is followed.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-31T13:49:45.000+00:00">31 December 2020</time>
              <p class="app-c-published-dates__change-note">Updated HTML and PDF attachments for 'Conditions of authorisation for Pfizer BioNTech'</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-30T17:40:38.000+00:00">30 December 2020</time>
              <p class="app-c-published-dates__change-note">Updated the Information for UK recipients and the Information for healthcare professionals documents, to reflect changes to the dosage interval, advice for women who are pregnant or breastfeeding and to those with allergies.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-24T19:17:54.000+00:00">24 December 2020</time>
              <p class="app-c-published-dates__change-note">Updated guidance for Healthcare Professionals on obtaining a sixth dose from a vial.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-16T16:03:41.000+00:00">16 December 2020</time>
              <p class="app-c-published-dates__change-note">Added an accessible HTML document: Summary of the Public Assessment Report</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-15T15:59:40.000+00:00">15 December 2020</time>
              <p class="app-c-published-dates__change-note">Added the Public Assessment Report for the Pfizer/BioNTech COVID-19 vaccine</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2020-12-10T19:23:24.000+00:00" class="app-c-published-dates__change-date timestamp">10 December 2020</time>
              <p class="app-c-published-dates__change-note">Changes to section 4.2 and 6 of the Information for UK Healthcare Professionals to provide clarification following further feedback and update to section 4.4 to strengthen information on special warnings and precautions for use.
Changes to warnings and precautions and clarification in section 6 of the Information for UK Recipients.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-08T14:40:45.000+00:00">8 December 2020</time>
              <p class="app-c-published-dates__change-note">Accessible HTML versions of both the 'Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine' and the 'Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine' are now available.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time datetime="2020-12-03T14:27:05.000+00:00" class="app-c-published-dates__change-date timestamp">3 December 2020</time>
              <p class="app-c-published-dates__change-note">A note regarding the ingredients has been added as well as an accessible HTML version of 'Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine'. A reference to the Medicines Act 1968 has been corrected.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-02T18:11:26.000+00:00">2 December 2020</time>
              <p class="app-c-published-dates__change-note">Added new document: Conditions of Authorisation for Pfizer BioNTech COVID-19 vaccine.</p>
            </li>
            <li class="app-c-published-dates__change-item">
              <time class="app-c-published-dates__change-date timestamp" datetime="2020-12-02T13:45:00.000+00:00">2 December 2020</time>
              <p class="app-c-published-dates__change-note">First published.</p>
            </li>
        </ol>
      </div>
</div>


      
    </div>
  </div>
  
<div class="govuk-grid-column-one-third">
  


</div>

</div>


  <div class="govuk-grid-row">
    <div class="govuk-grid-column-two-thirds">
        
  <div class="gem-c-contextual-footer">
    
  <div class="gem-c-related-navigation">





      <nav role="navigation" class="gem-c-related-navigation__nav-section" data-module="gem-toggle">

    <h2 data-track-count="footerRelatedItemSection" class="gem-c-related-navigation__sub-heading gem-c-related-navigation__sub-heading--footer">Explore the topic</h2>

  <ul data-module="gem-track-click" class="gem-c-related-navigation__link-list">


        <li class="gem-c-related-navigation__link"><a data-track-category="relatedLinkClicked" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-action="1.1 Explore the topic" data-track-label="/health-and-social-care/pharmacy" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Pharmacy&quot;}" href="/health-and-social-care/pharmacy">Pharmacy</a></li>
        <li class="gem-c-related-navigation__link"><a href="/coronavirus-taxon/vaccinations" class="govuk-link govuk-link gem-c-related-navigation__section-link govuk-link gem-c-related-navigation__section-link--footer" data-track-label="/coronavirus-taxon/vaccinations" data-track-action="1.2 Explore the topic" data-track-options="{&quot;dimension28&quot;:&quot;2&quot;,&quot;dimension29&quot;:&quot;Vaccinations for coronavirus&quot;}" data-track-category="relatedLinkClicked">Vaccinations for coronavirus</a></li>

  </ul>
</nav>

  </div>

  </div>


    </div>
  </div>


    </main>